{"status": "OK", "response": {"docs": [{"type_of_material": "Article", "blog": [], "news_desk": null, "lead_paragraph": "Unfortunately, no drug is completely \"safe.\" For example, there is a medication that, when administered in low doses, may cause indigestion and bleeding disorders, and, in higher doses, may result in marked alterations in blood chemistry, stupor, seizures and, on occasion, death. One would hardly expect a medication with such inherent toxicity to be approved for use by laboratory mice, let alone humans.", "headline": {"main": "Breaking the drug barrier"}, "abstract": "Richard Spark article on 'drug lag,' bureaucratic embargo on new drugs resulting from increasing consumer and Govt interest in benefit-vs-risk formula used to evaluate all drugs; FDA investigations and regulations discussed; illus (L)", "print_page": "228", "word_count": 1412, "_id": "4fc4941345c1498b0da6cadb", "snippet": "Unfortunately, no drug is completely \"safe.\" For example, there is a medication that, when administered in low doses, may cause indigestion and bleeding disorders, and, in higher doses, may result in marked alterations in blood  chemistry, stupor,...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/abstract.html?res=9D01E5D7113BE63BBC4851DFB566838C669EDE", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "DRUGS AND DRUG TRADE"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Richard", "rank": 1, "lastname": "Spark"}], "original": "By Richard Spark"}, "document_type": "article", "pub_date": "1977-03-20T00:00:00Z", "section_name": null}, {"type_of_material": "Article", "blog": [], "news_desk": null, "lead_paragraph": "WASHINGTON, March 14--For the Carter Administration, whose leader and top aides say that governmental reorganization and consumer protection are paramount among their priorities, the Food and Drug Administration may be the ultimate challenge.", "headline": {"main": "F.D.A. May Be Ultimate Challenge to Carter's Pledge on Reorganization and Consumer Aid"}, "abstract": "third and last article; FDA seen possibly becoming ultimate challenge to Carter Adm, which has assigned high priority to consumer protection and to govt reorganization (L)", "print_page": "24", "word_count": 2319, "_id": "4fc49fd145c1498b0daa0bd3", "snippet": "WASHINGTON, March 14--For the Carter Administration, whose leader and top aides say that governmental reorganization and consumer protection are paramount among their priorities, the Food and Drug Administration may be the ultimate challenge.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/abstract.html?res=9E0CEED81531EF30A25756C1A9659C946690D6CF", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "UNITED STATES"}, {"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "subject", "value": "DRUGS AND DRUG TRADE"}, {"name": "subject", "value": "SWEETENERS, ARTIFICIAL"}, {"name": "subject", "value": "CONSUMER PROTECTION"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1}], "original": "By RICHARD D.LYONS Special to The New York Times"}, "document_type": "article", "pub_date": "1977-03-15T00:00:00Z", "section_name": null}], "meta": {"hits": 2, "offset": 0, "time": 52}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}